Risk-adapted preemptive therapy for cytomegalovirus diseases after allogeneic hematopoietic stem cell transplantation [2]

Takehiko Mori; Yoshinobu Aisa; Tomonori Nakazato; Yasuo Ikeda; Shinichiro Okamoto

doi:10.1532/IJH97.05036

Risk-adapted preemptive therapy for cytomegalovirus diseases after allogeneic hematopoietic stem cell transplantation [2]

Takehiko Mori, Yoshinobu Aisa, Tomonori Nakazato, Yasuo Ikeda, Shinichiro Okamoto

Department of Internal Medicine (Hematology)

Research output: Contribution to journal › Letter › peer-review

3 Citations (Scopus)

Original language	English
Pages (from-to)	439-440
Number of pages	2
Journal	International journal of hematology
Volume	81
Issue number	5
DOIs	https://doi.org/10.1532/IJH97.05036
Publication status	Published - 2005 Jun 1

ASJC Scopus subject areas

Hematology

Access to Document

10.1532/IJH97.05036

Cite this

@article{51ac15731d66471e95e4acb882a1923a,

title = "Risk-adapted preemptive therapy for cytomegalovirus diseases after allogeneic hematopoietic stem cell transplantation [2]",

author = "Takehiko Mori and Yoshinobu Aisa and Tomonori Nakazato and Yasuo Ikeda and Shinichiro Okamoto",

year = "2005",

month = jun,

day = "1",

doi = "10.1532/IJH97.05036",

language = "English",

volume = "81",

pages = "439--440",

journal = "International journal of hematology",

issn = "0925-5710",

publisher = "Springer Japan",

number = "5",

}

TY - JOUR

T1 - Risk-adapted preemptive therapy for cytomegalovirus diseases after allogeneic hematopoietic stem cell transplantation [2]

AU - Mori, Takehiko

AU - Aisa, Yoshinobu

AU - Nakazato, Tomonori

AU - Ikeda, Yasuo

AU - Okamoto, Shinichiro

PY - 2005/6/1

Y1 - 2005/6/1

UR - http://www.scopus.com/inward/record.url?scp=21444434397&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=21444434397&partnerID=8YFLogxK

U2 - 10.1532/IJH97.05036

DO - 10.1532/IJH97.05036

M3 - Letter

C2 - 16158829

AN - SCOPUS:21444434397

SN - 0925-5710

VL - 81

SP - 439

EP - 440

JO - International journal of hematology

JF - International journal of hematology

IS - 5

ER -

Risk-adapted preemptive therapy for cytomegalovirus diseases after allogeneic hematopoietic stem cell transplantation [2]

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this